Orally disintegrating, sublingual and buccal formulations
a technology of oral dissolution and oral cavity, applied in the direction of pharmaceutical delivery mechanism, plant/algae/fungi/lichens ingredients, organic active ingredients, etc., can solve the problems of delayed and unpredictable onset of effects, inconsistent dosing,
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Solid Tablet CBD Formulation
[0041]This example describes a method of producing a solid tablet described herein. In particular, the solid tablet is fast-dissolving.
[0042]Procedure
[0043]Ensure correct environment is attained prior to tablet production
[0044]Temperature: 68-72° F.
[0045]Relative humidity: 44-50%
[0046]Cannabis Extract Mix
[0047]In a 100 mL beaker, slowly add 0.25 mL of cannabis extract (40 mg / mL MCT oil extraction) to 240.0 mg of silicon dioxide
[0048]Triturate the resulting mixture to ensure even absorption and distribution of cannabis extract in the silicon dioxide
[0049]Sieve mixture with #8 size sieve to ensure uniform powder
[0050]Inactive Ingredient Mix (“Core component mix”)
[0051]In a separate 100 mL beaker mix the following ingredients: 24.0 mg mannitol, 120.0 mg citric acid, 12.0 mg sodium bicarbonate, 40.0 mg of calcium carbonate, 200.0 mg dibasic calcium phosphate anhydrous, 0.3 mg menthol extract, and 40.0 mg sodium citrate
[0052]Combine these ingredients and tritu...
example 2
Orally Disintegrating / Sublingual / Buccal Formulations Provide Rapid Onset of Effects
[0060]This example demonstrates that oral formulations described herein provide rapid onset and peak effects of an active ingredient. The effects of exemplary oral formulations described herein were measured against a control. Subjects were assigned to receive either an active (n=7) or placebo (n=1) formulation lacking an active ingredient. The subject characteristics are described in the table below.
TABLE 2ActivePlaceboSex, n (%)Male4 (50.0)1 (100.0)Female3 (50.0)0 (0.0) Mean Age, years34.67 + / − 11.432.0 + / − 0.0Prior Cannabis UserYesYes
[0061]The effects of the formulations were measured over a 120 minute period. No subject was lost to follow up or excluded from the analysis.
[0062]The results of the analysis are provided in FIG. 1, which shows the effects of the active over time. As shown in the FIGURE, A=acidic ingredient, where A is citric acid, and B=basic ingredient, where B is sodium carbonate / ca...
PUM
| Property | Measurement | Unit |
|---|---|---|
| temperature | aaaaa | aaaaa |
| concentration | aaaaa | aaaaa |
| concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 
